Showing posts with label pandemics. Show all posts
Showing posts with label pandemics. Show all posts

Wednesday, November 12, 2014

When Influenza Goes Rogue

image

Variability of Flu Seasons - Mash up from Multiple FluView Reports

 


# 9311

 

Most people are aware that over the past century we’ve seen 4 influenza pandemics; the 1918 Spanish Flu, the 1957 Asian Flu, 1968 Hong Kong Flu & the 2009 H1N1 pandemic. Of these, the 1918 pandemic was (by far) the worst, but each of the others exacted a heavy toll as well.


Less well known have been the `rogue’ flu years, when we saw something less than a pandemic, but something substantially worse than a typical flu season.

 

There is, of course, a good deal of variance between `normal’ flu seasons (see chart above), with significant jumps in P&I (Pneumonia & Influenza) mortality registered in the years 2000,  2003 and 2013, while 2012 was the mildest year for influenza in decades.

 

As a paramedic, I worked the `pseudo-pandemic’ of 1977, and I can attest that it had a big impact, even if it didn’t rise to the level of a global pandemic.  In that case, an old nemesis – H1N1 – which had disappeared 20 years earlier after the arrival of H2N2 in the 1957 pandemic, came back.

 

While the exact mechanism of that virus’ return isn’t known, the strain was so similar to one last seen in the 1950s that it has been postulated that it was the result of an accidental lab release in China or Russia (see PLoS ONe The Re-Emergence of H1N1 Influenza Virus in 1977 . . . ).  Hence, it was dubbed the `Russian Flu’.


Those over the age of 20 (I made the cut by 3 years), carried some immunity to the old H1N1 virus, but children and adolescents born after 1957 did not, and so they were the most susceptible to infection.  Emergency rooms were slammed, and while the impact was limited and most patients recovered, in some people’s books 1977 qualifies as a `pseudo-pandemic’ year . . . at least for kids.


H1N1’s impact went far beyond just what happened in 1977, for for the first time in our limited knowledge of influenza strains, we ended up having two seasonal influenza A strains in co-circulation; H3N2 and H1N1. Something that previously, had never been observed.


Another, less well remembered event, was the `Liverpool Flu’ of 1951, which for awhile, killed at a greater rate than did the Great Influenza of 1918.

 

For most of the world, 1951 was an average flu year.  The dominant strain of influenza that year was the so-called `Scandinavian strain', which produced mild illness in most of its victims. In fact, if you look at a graph of flu activity for the United States, running from 1945 to 1956, you'll see nary a blip.

1946-1956

 

But in December of 1950 a new strain of virulent influenza appeared in Liverpool, England, and by the end of the flu season, had spread across much of England, Wales, and Canada. This from an absolutely fascinating EID Journal article: Viboud C, Tam T, Fleming D, Miller MA, Simonsen L. 1951 influenza epidemic, England and Wales, Canada, and the United States.

 

The 1951 influenza epidemic (A/H1N1) caused an unusually high death toll in England; in particular, weekly deaths in Liverpool even surpassed those of the 1918 pandemic. . . . . Why this epidemic was so severe in some areas but not others remains unknown and highlights major gaps in our understanding of interpandemic influenza.

 

According to this study, the effects on the city of origin, Liverpool, were horrendous.

 

In Liverpool, where the epidemic was said to originate, it was "the cause of the highest weekly death toll, apart from aerial bombardment, in the city's vital statistics records, since the great cholera epidemic of 1849" (5). This weekly death toll even surpassed that of the 1918 influenza pandemic (Figure 1)

liverpool

 

This extraordinary graph shows the excess deaths in Liverpool during this outbreak (red line),  while the black line shows the peak deaths during the 1918 pandemic.  This chart shows excess deaths by   A) respiratory causes (pneumonia, influenza and bronchitis) and B) all causes.

 

For roughly 5 weeks Liverpool saw an incredible spike in deaths due to this new influenza.   And it didn’t remain localized.  While it appears not to have spread as easily as the dominant Scandinavian strain, it managed to infect large areas of England, Wales, and Canada over the ensuing months.

 

Getting started relatively late in the flu season, this new strain never managed to spread much beyond UK and Eastern Canada.  Nor did it reappear the next flu season.  It vanished as mysteriously as it appeared.

 

Another example, but one that affected the transmissibility and not the virulence of the seasonal virus, occurred in 1947.  The so-called `vaccine failure’ year, when a new H1N1 virus swept quickly around the world.

 

In 1947 a new variant of the H1N1 virus appeared on military bases – first noticed in Japan – and quickly spread from there. While it produced a generally mild illness there were apparently low levels of immunity in the population (see EID Journal Influenza Pandemics of the 20th Century).  1947 is little remembered today, except by epidemiologists, because while widespread, this new flu strain produced few excess deaths.

.

And then there were the epidemics that might have been – but that for reasons unknown – didn’t happen.

 

In early 1976, after an absence of nearly two decades, a never-before-seen strain of H1N1 swine flu appeared at Ft. Dix, New Jersey – prompting a national emergency response for its expected return in the fall.  While that failed to happen (see Deja Flu, All Over Again), the following year we were blindsided by the `Russian’ H1N1 flu described above.


Why the 1976 H1N1 Swine flu fizzled out remains a mystery.

 

As we go into each year’s flu season, we are always presented with a  `Forrest Gump’ moment. We never quite know what we are going to get.

 

But we do know that even in a non-pandemic year, we can see tens of thousands of American lives lost due to influenza. Globally, we are talking hundreds of thousands. And that a season can start off mild and unassuming (like 1950) and end up as a raging epidemic. 

 

We also know that a flu season can affect different parts of the world differently.  We may very well see an H3N2-centric flu season this year in North America, but in Europe or Asia, they could easily see H1N1 instead.

 

While every year is a question mark, this year we have a number of additional variables at play. The first comes from the rise in the number of antigenically diverse H3N2 clades being reported around the world (see ECDC: Influenza Characterization – Sept 2014). 

 

Since this fall’s vaccine strains were selected last February, the `balance of power’ among flu H3N2 flu strains has begun to shift, and the H3N2 component for next year’s Southern Hemisphere flu shot has already been changed to meet the challenge of an emerging A/Switzerland/9715293/2013 (H3N2)-like virus. 


Complicating matters, last week it was announced that last year’s LAIV (Live Attenuated Influenza Vaccine)  –  aka FluMist nasal spray vaccine – was not effective against the H1N1(pdm) virus in children aged 2-8, and that it is likely to be ineffective this year as well.

 

And if all of this isn’t enough uncertainty, this year we are watching more novel flu strains than ever before;  H7N9, H5N1, H5N6, H5N2, H5N8, H5N3, H9N2 and H10N8 just to mention the biggest concerns.  You’ll find an excellent overview of these emerging avian flu threats in this weeks’ FAO-EMPRES Report On The Emergence And Threat Of H5N6.

 

As I’ve written here often , flu vaccines are considered very safe – and most years provide a moderate level of protection against influenza. While there are some questions regarding this year’s vaccine `match’ with circulating strains, some protection beats no protection any day of the week.

 

While the vaccine can’t promise 100% protection, it – along with practicing good flu hygiene (washing hands, covering coughs, & staying home if sick) – remains your best strategy for avoiding the flu (and other viruses) this winter.

 

Meanwhile, we have what is shaping up to be a fascinating year for studying all types of flu viruses. 

Tuesday, March 25, 2014

WHO Director Chan: The Next New Virus Lurks . . .

image

Photo Credit WHO

 


# 8399

 

 

The World Health Organization’s Director General Margaret Chan, addressing the Credit Suisse Asian investment conference in Hong Kong yesterday, warned that - despite the fact that the world was better equipped to deal with infectious disease outbreaks than ever before - dangerous new diseases will continue to emerge, and that the pace of new emerging health threats was accelerating.


A full transcript of Director Chan’s remarks can be found at:

 

WHO Director-General addresses the Asian Investment Conference

Dr Margaret Chan

Director-General of the World Health Organization

Keynote address at the 2014 Credit Suisse
Asian Investment Conference: Are we winning the fight against infectious diseases?
Hong Kong, the People's Republic of China
24 March 2014

In this address, Director Chan addresses numerous topics, including the industrialization of food production, the threat of growing antibiotic resistance, and the potential for climate change to exacerbate the emergence of new disease threats . . . to name just a few.  


Her address is well worth reading in its entirety, but I’ve excerpted a few passages:

Today, the biggest threat from infectious diseases comes from the unknown: the next new virus lurking in the jungles of sub-Saharan Africa or in the wet markets and teeming cities of Asia.

These two geographical areas have traditionally been regarded as the breeding ground for new diseases. Around 75% of new diseases emerge following close contact between humans and domestic or wild animals. Africa and Asia offer multiple opportunities for these contacts to occur.

<snip>

A strong preference for freshly slaughtered poultry keeps the wet markets open in several parts of Asia. Most scientists view wet markets as hotspots for the emergence of new viruses that could spark the next influenza pandemic.

The practice or raising chickens near homes has been the source of numerous human cases of H5N1 infection, also among very young children who play or crawl near birds or their droppings.

All of these trends, like unprecedented population density, incursions into previously uninhabited areas, people crowded together with domestic animals, a changing climate, and the industrialization of food production, put our world on a dangerous trajectory, with new diseases just one of many prices to pay.

 

Local media coverage, as provided below by the Hong Kong Standard, understandably focused primarily on her remarks regarding the importation and sale of live poultry in the wake of the year-long outbreak of H7N9 in China. 

 

Although a temporary ban is in place, the long-term policy regarding live poultry imports remains uncertain, with many top scientists urging that the ban not be lifted.

 

This from the Hong Kong Standard.

 

WHO chief urges end to sale of live poultry

Mary Ann Benitez

Tuesday, March 25, 2014

The World Health Organization director- general Margaret Chan Fung Fu-chun is urging Hong Kong to consider banning the sale of live poultry to stop bird flu.

Speaking at a conference in the territory, Chan said that wet markets are a breeding ground for the deadly new diseases. But Chan, the territory's former director of health, said that it would be difficult to impose a ban because of the local preference for fresh chicken.

(Continue . . . )

 

 

The evidence that closing live-bird markets reduces the spread of avian flu viruses is pretty solid (see The Lancet: Poultry Market Closure Effect On H7N9 Transmission), making it an obvious mitigation strategy.  But old habits die hard; purchasing live market birds is deeply ingrained in the Chinese culture, and there has been much public resistance to closing these markets.


Which illustrates the fact that public health policies cannot be made in a scientific vacuum; that economic, political, and societal factors (which vary widely around the world) will always influence what can – and what cannot – be readily accomplished.

 

While outbreaks of exotic diseases, or the specter of a pandemic, typically garners the biggest headlines, the bulk of Director Chan’s remarks were related to the growing antibiotic resistance crisis -  which, if it continues – truly threatens a dark future for all aspects of medicine.  A few excerpts:

 

We are losing our first-line antibiotics, our miracle cures. Replacement treatments are more costly, more toxic, need much longer durations of treatment, and may require treatment in intensive care units. For some diseases, the death rate doubles when drug resistance develops.

Many common bacteria have developed resistance to multiple drugs, some to nearly all. Hospitals have become hotbeds for highly-resistant superbugs, increasing the risk that hospitals kill rather than heal. These are end-of-the-road pathogens that are resistant to last-line drugs.

If current trends continue, the future is easy to predict. Some experts say we are moving back to the pre-antibiotic era. No. This will be a post-antibiotic era. In terms of new replacement antibiotics, the pipeline is virtually dry, the cupboard is nearly bare.

A post-antibiotic era means, in effect, an end to modern medicine as we know it. Common infections will once again kill. Some sophisticated interventions, like hip replacements, organ transplants, cancer chemotherapy, and care of preterm infants, will become far more difficult or even too dangerous to undertake.

Even simple interventions, like surgery to treat myopia, will become too dangerous to perform.

 

While a stark prediction, in some places in the world – and with some bacterial infections – we are already there (see ECDC/WHO: World TB Day - Focus On MDR & XDR Treatment Outcomes).

 

In EU, only 1 in every 3 MDR TB patients has a successful treatment outcome; more than half either die, fail treatment or default (stop taking treatment). XDR TB has even worse treatment outcomes: only 1 in 4 patients finishes treatment successfully

 

For more on the spread of antibiotic resistance around the globe, you may wish to revisit:

 

EID Journal: Acquisition of Drug Resistant Genes Through International Travel
UK CMO: Antimicrobial Resistance Poses `Catastrophic Threat’
MMWR Vital Signs: Carbapenem-Resistant Enterobacteriaceae (CRE)
Chan: World Faces A `Post-Antibiotic Era’